A bipartisan way to make prescription drugs affordable

National Review

22 October 2019 - To encourage medical innovation while removing costly gimmicks, pass PDPRA.

Americans are concerned about the high price of drugs. The pharmaceutical industry has become a system rife with gaming. Profits are regularly prioritised over patients. 

Laws meant to encourage innovation, recoup private investment, and ensure patient access are too often manipulated to suppress competition and increase prices.

Read National Review article

Michael Wonder

Posted by:

Michael Wonder